News
Zacks Investment Research on MSN19h
Will The Decline in Legacy Drugs Pull Down BMY's Top Line?Bristol Myers’ BMY legacy portfolio comprises Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane. Revenues for the Legacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback